Establishment and Biological Characterization of a Panel of Glioblastoma Multiforme (GBM) and GBM Variant Oncosphere Cell Lines

被引:19
|
作者
Binder, Zev A. [1 ,2 ,3 ,7 ]
Wilson, Kelli M. [1 ,8 ]
Salmasi, Vafi [1 ,9 ]
Orr, Brent A. [4 ,10 ]
Eberhart, Charles G. [4 ]
Siu, I-Mei [1 ]
Lim, Michael [1 ,5 ]
Weingart, Jon D. [1 ,5 ]
Quinones-Hinojosa, Alfredo [1 ,5 ]
Bettegowda, Chetan [1 ,5 ]
Kassam, Amin B. [6 ]
Olivi, Alessandro [1 ,5 ]
Brem, Henry [1 ,5 ]
Riggins, Gregory J. [1 ,5 ]
Gallia, Gary L. [1 ,5 ]
机构
[1] Johns Hopkins Univ, Sch Med, Dept Neurosurg, Baltimore, MD 21205 USA
[2] Johns Hopkins Univ, Johns Hopkins Phys Sci Oncol Ctr, Baltimore, MD USA
[3] Johns Hopkins Univ, Inst NanoBioTechnol, Baltimore, MD USA
[4] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA
[5] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA
[6] Aurora Neurosci Innovat Inst, Dept Neurosurg, Milwaukee, WI USA
[7] Univ Penn, Dept Neurosurg, Philadelphia, PA 19104 USA
[8] NIH, Div Preclin Innovat, Chem Genom Ctr, Natl Ctr Adv Translat Sci, Rockville, MD USA
[9] Cleveland Clin, Inst Anesthesiol, Cleveland, OH 44106 USA
[10] St Jude Childrens Res Hosp, Dept Pathol, 332 N Lauderdale St, Memphis, TN 38105 USA
来源
PLOS ONE | 2016年 / 11卷 / 03期
基金
美国国家卫生研究院;
关键词
STEM-CELLS; CROSS-CONTAMINATION; TUMOR; RESISTANCE; PHENOTYPE; GENOTYPE; CULTURE; GROWTH;
D O I
10.1371/journal.pone.0150271
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Objective Human tumor cell lines form the basis of the majority of present day laboratory cancer research. These models are vital to studying the molecular biology of tumors and preclinical testing of new therapies. When compared to traditional adherent cell lines, suspension cell lines recapitulate the genetic profiles and histologic features of glioblastoma multiforme (GBM) with higher fidelity. Using a modified neural stem cell culture technique, here we report the characterization of GBM cell lines including GBM variants. Methods Tumor tissue samples were obtained intra-operatively and cultured in neural stem cell conditions containing growth factors. Tumor lines were characterized in vitro using differentiation assays followed by immunostaining for lineage-specific markers. In vivo tumor formation was assayed by orthotopic injection in nude mice. Genetic uniqueness was confirmed via short tandem repeat (STR) DNA profiling. Results Thirteen oncosphere lines derived from GBM and GBM variants, including a GBM with PNET features and a GBM with oligodendroglioma component, were established. All unique lines showed distinct genetic profiles by STR profiling. The lines assayed demonstrated a range of in vitro growth rates. Multipotency was confirmed using in vitro differentiation. Tumor formation demonstrated histologic features consistent with high grade gliomas, including invasion, necrosis, abnormal vascularization, and high mitotic rate. Xenografts derived from the GBM variants maintained histopathological features of the primary tumors. Conclusions We have generated and characterized GBM suspension lines derived from patients with GBMs and GBM variants. These oncosphere cell lines will expand the resources available for preclinical study.
引用
收藏
页数:18
相关论文
共 50 条
  • [1] Establishment and partial characterization of a human tumor cell line, GBM-HSF, from a glioblastoma multiforme
    Qu, Jiagui
    Rizak, Joshua D.
    Fan, Yaodong
    Guo, Xiaoxuan
    Li, Jiejing
    Huma, Tanzeel
    Ma, Yuanye
    [J]. HUMAN CELL, 2014, 27 (03): : 129 - 136
  • [2] Establishment and partial characterization of a human tumor cell line, GBM-HSF, from a glioblastoma multiforme
    Jiagui Qu
    Joshua D. Rizak
    Yaodong Fan
    Xiaoxuan Guo
    Jiejing Li
    Tanzeel Huma
    Yuanye Ma
    [J]. Human Cell, 2014, 27 : 129 - 136
  • [3] ESTABLISHMENT OF GBM SUSPENSION CELL LINES
    Binder, Zev A.
    Salmasi, Vafi
    Lim, Michael
    Weingart, Jon
    Brem, Henry
    Olivi, Alessandro
    Riggins, Gregory J.
    Gallia, Gary L.
    [J]. NEURO-ONCOLOGY, 2010, 12 : 134 - 134
  • [4] Establishment and characterisation of primary GBM cell lines
    Mullins, C.
    Linnebacher, M.
    Schneider, B.
    Stockhammer, F.
    Classen, C. F.
    [J]. KLINISCHE PADIATRIE, 2011, 223 (06): : 399 - 399
  • [5] MIR-185 IS LOST IN GLIOBLASTOMA MULTIFORME (GBM) AND INHIBITS PROLIFERATION IN GLIOMA CELL LINES
    Morrow, Colin
    Smirnov, Ivan
    Adai, Alex
    Yeh, Ru-Fang
    Mistra, Anajan
    Feuerstein, Burt
    [J]. NEURO-ONCOLOGY, 2008, 10 (05) : 767 - 767
  • [6] Using Light for Therapy of Glioblastoma Multiforme (GBM)
    Vasilev, Alex
    Sofi, Roba
    Rahman, Ruman
    Smith, Stuart J.
    Teschemacher, Anja G.
    Kasparov, Sergey
    [J]. BRAIN SCIENCES, 2020, 10 (02)
  • [7] Overexpression of osteopontin (OPN) in glioblastoma multiforme (GBM).
    Haddix, TL
    Recht, LD
    Myles, T
    Leung, LLK
    Vogel, H
    [J]. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2005, 64 (05): : 456 - 456
  • [8] Fotemustine in recurrent or progressive glioblastoma multiforme (GBM)
    Savio, G.
    Pepe, A.
    Laudani, A.
    Leonardi, V
    Usset, A.
    Rondello, G.
    Arcuri, C.
    Palmisano, V
    Alu', M.
    Macaluso, M.
    Agostara, B.
    [J]. ANNALS OF ONCOLOGY, 2007, 18 : 80 - 80
  • [9] MR imaging and spectroscopic findings in giant cell glioblastoma multiforme (GBM)
    VanderMeer, C
    Castillo, M
    Kwock, L
    Bouldin, T
    [J]. AMERICAN JOURNAL OF ROENTGENOLOGY, 2004, 182 (04) : 21 - 21
  • [10] COMPUTATIONAL APPROACH TO IDENTIFYING NEUROINFLAMMATION IN GLIOBLASTOMA MULTIFORME (GBM)
    Sherman, Wendy
    Martin, Katie
    Rossell, Larissa
    Nguyen, Kelly
    Grady, Pamela
    Zimmermann, Cynthia
    Chesla, David
    Mackeigan, Jeffrey
    [J]. NEURO-ONCOLOGY, 2020, 22 : 74 - 74